Predicting the development of RA in patients with early undifferentiated arthritis

Best Practice and Research: Clinical Rheumatology

Volumn 23, Issue 1, 2009, Pages 25-36

  Raza, Karim ^a   Filer, Andrew ^a  

^a Institute of Biomedical Research   (United Kingdom)

Author keywords

anti CCP antibody; early arthritis; magnetic resonance imaging; outcome; prediction; rheumatoid arthritis; synovitis; ultrasound

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; RHEUMATOID FACTOR;

BONE EROSION; DISEASE CLASSIFICATION; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; GENETIC ASSOCIATION; HEREDITY; HUMAN; JOINT RADIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SYNOVIAL FLUID; SYNOVITIS;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; PREDICTIVE VALUE OF TESTS;

EID: 60749118572     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2008.08.001     Document Type: Review

References (84)

1. Tunn E.J., and Bacon P.A. Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol 32 (1993) 97-103 [see comments]
2. Harrison B.J., Symmons D.P., Brennan P., et al. Natural remission in inflammatory polyarthritis: issues of definition and prediction. Br J Rheumatol 35 (1996) 1096-1100
3. Raza K., Buckley C.E., Salmon M., and Buckley C.D. Treating very early rheumatoid arthritis. Best Pract Res Clin Rheumatol 20 (2006) 849-863
4. Nell V.P., Machold K.P., Eberl G., et al. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 43 (2004) 906-914
5. Mottonen T., Hannonen P., Korpela M., et al. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 46 (2002) 894-898
6. Hyrich K.L. Patients with suspected rheumatoid arthritis should be referred early to rheumatology. BMJ 336 (2008) 215-216
7. Green M., Marzo-Ortega H., McGonagle D., et al. Persistence of mild, early inflammatory arthritis: the importance of disease duration, rheumatoid factor, and the shared epitope. Arthritis Rheum 42 (1999) 2184-2188
8. Schellekens G.A., Visser H., de Jong B.A., et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43 (2000) 155-163
9. Goldbach-Mansky R., Lee J., McCoy A., et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2 (2000) 236-243
10. Visser H., le Cessie S., Vos K., et al. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46 (2002) 357-365
11. Harrison B., and Symmons D. Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years. Rheumatology (Oxford) 39 (2000) 939-949
12. Huizinga T.W., Machold K.P., Breedveld F.C., et al. Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis. Arthritis Rheum 46 (2002) 1155-1159
13. Symmons D.P. Classification criteria for rheumatoid arthritis - time to abandon rheumatoid factor?. Rheumatology (Oxford) 46 (2007) 725-726
14. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
15. Kaarela K., Kauppi M.J., and Lehtinen K.E. The value of the ACR 1987 criteria in very early rheumatoid arthritis. Scand J Rheumatol 24 (1995) 279-281
16. Raza K., Breese M., Nightingale P., et al. Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol 32 (2005) 231-238
17. Nell V.P., Machold K.P., Stamm T.A., et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64 (2005) 1731-1736
18. van der Helm-van Mil A.H., le Cessie S., van Dongen H., et al. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 56 (2007) 433-440
19. van der Helm-van Mil A.H., Detert J., le Cessie S., et al. Moving towards individualized treatment decision making: validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis. Arthritis Rheum 58 (2008) 2241-2247
20. Harrison B.J., Symmons D.P., Barrett E.M., and Silman A.J. The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association. J Rheumatol 25 (1998) 2324-2330
21. Mathsson L., Mullazehi M., Wick M.C., et al. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum 58 (2008) 36-45
22. Kinloch A., Tatzer V., Wait R., et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 7 (2005) R1421-R1429
23. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298 (1978) 869-871
24. van der Helm-van Mil A.H., Verpoort K.N., Breedveld F.C., et al. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 54 (2006) 1117-1121
25. Begovich A.B., Carlton V.E., Honigberg L.A., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75 (2004) 330-337
26. Wesoly J., van der Helm-van Mil A.H., Toes R.E., et al. Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort. Arthritis Rheum 52 (2005) 2948-2950
27. Kurreeman F.A., Padyukov L., Marques R.B., et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Medicine 4 (2007) e278
28. Plenge R.M., Seielstad M., Padyukov L., et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med 357 (2007) 1199-1209
29. Thomson W., Barton A., Ke X., et al. Rheumatoid arthritis association at 6q23. Nat Genet 39 (2007) 1431-1433
30. Irigoyen P., Lee A.T., Wener M.H., et al. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 52 (2005) 3813-3818
31. Verpoort K.N., Van Gaalen F.A., van der Helm-van Mil A.H., et al. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum 52 (2005) 3058-3062
32. Sigurdsson S., Padyukov L., Kurreeman F.A., et al. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum 56 (2007) 2202-2210
33. Garnier S., Dieude P., Michou L., et al. IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis. Ann Rheum Dis 66 (2007) 828-831
34. Rueda B., Reddy M.V., Gonzalez-Gay M.A., et al. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis. Arthritis Rheum 54 (2006) 3815-3819
35. van Oosterhout M., Bajema I., Levarht E.W., et al. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum 58 (2008) 53-60
36. van der Helm-van Mil A.H., and Huizinga T.W. Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res Ther 10 (2008) 205
37. Schumacher H.R., and Kitridou R.C. Synovitis of recent onset. A clinicopathologic study during the first month of disease. Arthritis Rheum 15 (1972) 465-485
38. Schumacher Jr. H.R., Bautista B.B., Krauser R.E., et al. Histological appearance of the synovium in early rheumatoid arthritis. Semin Arthritis Rheum 23 (1994) 3-10
39. Singh J.A., Pando J.A., Tomaszewski J., and Schumacher H.R. Quantitative analysis of immunohistologic features of very early rheumatoid synovitis in disease modifying antirheumatic drug- and corticosteroid-naive patients. J Rheumatol 31 (2004) 1281-1285
40. Gerlag D.M., and Tak P.P. How useful are synovial biopsies for the diagnosis of rheumatic diseases?. Nat Clin Pract Rheumatol 3 (2007) 248-249
41. Raza K., Lee C.Y., Pilling D., et al. Ultrasound guidance allows accurate needle placement and aspiration from small joints in patients with early inflammatory arthritis. Rheumatology (Oxford) 42 (2003) 976-979
42. Kane D., Veale D.J., FitzGerald O., and Reece R. Survey of arthroscopy performed by rheumatologists. Rheumatology (Oxford) 41 (2002) 210-215
43. Koski J.M., and Helle M. Ultrasound guided synovial biopsy using portal and forceps. Ann Rheum Dis 64 (2005) 926-929
44. Scire C.A., Epis O., Codullo V., et al. Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure. Arthritis Res Ther 9 (2007) R101
45. Raza K., Falciani F., Curnow S.J., et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 7 (2005) R784-R795
46. Raza K., Scheel-Toellner D., Lee C.Y., et al. Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis. Rheumatology 45 (2006) 33
47. Goldbach-Mansky R., Lee J.M., Hoxworth J.M., et al. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res 2 (2000) 145-153
48. Humby F., Manzo A., Kirkham B., and Pitzalis C. The synovial membrane as a prognostic tool in rheumatoid arthritis. Autoimmun Rev 6 (2007) 248-252
49. Klimiuk P.A., Goronzy J.J., Bjor n J., et al. Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am J Pathol 151 (1997) 1311-1319
50. Klimiuk P.A., Sierakowski S., Latosiewicz R., et al. Serum cytokines in different histological variants of rheumatoid arthritis. J Rheumatol 28 (2001) 1211-1217
51. Thurlings R.M., Wijbrandts C.A., Mebius R.E., et al. Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype. Arthritis Rheum 58 (2008) 1582-1589
52. Schroder A.E., Greiner A., Seyfert C., and Berek C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci U S A 93 (1996) 221-225
53. Chen H.Y., Yu S.L., Chen C.H., et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356 (2007) 11-20
54. Patocs A., Zhang L., Xu Y., et al. Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 357 (2007) 2543-2551
55. Van Der Pouw Kraan T.C., Van Gaalen F.A., Huizinga T.W., et al. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes Immun 4 (2003) 187-196
56. Kasperkovitz P.V., Timmer T.C., Smeets T.J., et al. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. Arthritis Rheum 52 (2005) 430-441
57. Stanczyk J., Pedrioli D.M., Brentano F., et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 58 (2008) 1001-1009
58. Batliwalla F.M., Baechler E.C., Xiao X., et al. Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immun 6 (2005) 388-397
59. Van Der Pouw Kraan T.C., van Baarsen L.G., Wijbrandts C.A., et al. Expression of a pathogen-response program in peripheral blood cells defines a subgroup of rheumatoid arthritis patients. Genes Immun 9 (2008) 16-22
60. Prevoo M.L., 't Hof M.A., Kuper H.H., et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38 (1995) 44-48
61. Felson D.T., Anderson J.J., Boers M., et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 36 (1993) 729-740
62. Khanna D., Oh M., Furst D.E., et al. Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort. Arthritis Rheum 57 (2007) 440-447
63. Szkudlarek M., Narvestad E., Klarlund M., et al. Ultrasonography of the metatarsophalangeal joints in rheumatoid arthritis: comparison with magnetic resonance imaging, conventional radiography, and clinical examination. Arthritis Rheum 50 (2004) 2103-2112
64. Szkudlarek M., Klarlund M., Narvestad E., et al. Ultrasonography of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis: a comparison with magnetic resonance imaging, conventional radiography and clinical examination. Arthritis Res Ther 8 (2006) R52
65. Kane D., Balint P.V., and Sturrock R.D. Ultrasonography is superior to clinical examination in the detection and localization of knee joint effusion in rheumatoid arthritis. J Rheumatol 30 (2003) 966-971
66. Wakefield R.J., Green M.J., Marzo-Ortega H., et al. Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis 63 (2004) 382-385
67. Brown A.K., Quinn M.A., Karim Z., et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 54 (2006) 3761-3773
68. Pando J.A., Duray P., Yarboro C., et al. Synovitis occurs in some clinically normal and asymptomatic joints in patients with early arthritis. J Rheumatol 27 (2000) 1848-1854
69. Balint P.V., Kane D., Wilson H., et al. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 61 (2002) 905-910
70. Szkudlarek M., Court-Payen M., Strandberg C., et al. Power Doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis: a comparison with dynamic magnetic resonance imaging. Arthritis Rheum 44 (2001) 2018-2023
71. Taylor P.C., Steuer A., Gruber J., et al. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum 50 (2004) 1107-1116
72. Schmidt W.A., Volker L., Zacher J., et al. Colour Doppler ultrasonography to detect pannus in knee joint synovitis. Clin Exp Rheumatol 18 (2000) 439-444
73. Walther M., Harms H., Krenn V., et al. Correlation of power Doppler sonography with vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 44 (2001) 331-338
74. El M.Y., Youssef S., Mehanna A.N., and El G.M. Development of a scoring system for assessment of outcome of early undifferentiated inflammatory synovitis. Joint Bone Spine 75 (2008) 155-162
75. Wakefield R.J., Gibbon W.W., Conaghan P.G., et al. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum 43 (2000) 2762-2770
76. Scheel A.K., Hermann K.G., Ohrndorf S., et al. Prospective 7 year follow up imaging study comparing radiography, ultrasonography, and magnetic resonance imaging in rheumatoid arthritis finger joints. Ann Rheum Dis 65 (2006) 595-600
77. Tan A.L., Tanner S.F., Conaghan P.G., et al. Role of metacarpophalangeal joint anatomic factors in the distribution of synovitis and bone erosion in early rheumatoid arthritis. Arthritis Rheum 48 (2003) 1214-1222
78. Haavardsholm E.A., Boyesen P., Ostergaard M., et al. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis 67 (2008) 794-800
79. McQueen F.M., Benton N., Perry D., et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 48 (2003) 1814-1827
80. Hetland M.L., Ejbjerg B.J., Horslev-Petersen K., et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2 year randomized controlled trial (CIMESTRA). Ann Rheum Dis (2008)
81. McGonagle D., Conaghan P.G., O'Connor P., et al. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: a controlled magnetic resonance imaging study. Arthritis Rheum 42 (1999) 1706-1711
82. Conaghan P.G., O'Connor P., McGonagle D., et al. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum 48 (2003) 64-71
83. Narvaez J, Sirvent E, Antonio NJ, et al. Usefulness of magnetic resonance imaging of the hand versus anticyclic citrullinated peptide antibody testing to confirm the diagnosis of clinically suspected early rheumatoid arthritis in the absence of rheumatoid factor and radiographic erosions. Semin Arthritis Rheum (in press).
84. Olech E., Freeston J.E., Conaghan P.G., et al. Using extremity magnetic resonance imaging to assess and monitor early rheumatoid arthritis: the optimal joint combination to be scanned in clinical practice. J Rheumatol 35 (2008) 580-583